AAPL326.57+11.23 (+3.56%) ▲|ABBV255.00+4.09 (+1.63%) ▲|ABT103.36-1.87 (-1.78%) ▼|ACN177.91+2.11 (+1.20%) ▲|ADBE248.83-6.03 (-2.37%) ▼|AMAT454.01-14.84 (-3.17%) ▼|AMD503.60-17.50 (-3.36%) ▼|AMGN382.47-8.80 (-2.25%) ▼|AMT172.98-2.45 (-1.40%) ▼|AMZN251.89-0.51 (-0.20%) ▼|AVGO360.83-3.55 (-0.97%) ▼|AXP320.71-1.09 (-0.34%) ▼|BA204.80-1.62 (-0.78%) ▼|BAC62.56-0.11 (-0.18%) ▼|BKNG174.33+0.90 (+0.52%) ▲|BLK1,062.40-9.63 (-0.90%) ▼|BMY63.75-0.66 (-1.02%) ▼|BNY162.59+0.08 (+0.05%) ▲|BRK-B507.00+0.28 (+0.06%) ▲|C138.50+0.70 (+0.51%) ▲|CAT805.00-10.56 (-1.29%) ▼|CL87.90-0.13 (-0.15%) ▼|CMCSA25.17+0.58 (+2.36%) ▲|COF207.11-3.75 (-1.78%) ▼|COP137.04+0.51 (+0.37%) ▲|COST902.38-0.22 (-0.02%) ▼|CRM243.00-1.16 (-0.48%) ▼|CSCO107.44-1.99 (-1.82%) ▼|CVS95.29-0.09 (-0.09%) ▼|CVX212.76-1.05 (-0.49%) ▼|DE677.94+0.73 (+0.11%) ▲|DHR200.53-4.32 (-2.11%) ▼|DIS105.82+1.64 (+1.57%) ▲|DUK119.37-1.06 (-0.88%) ▼|EMR148.37-1.97 (-1.31%) ▼|FDX311.80+2.61 (+0.84%) ▲|GD354.25+1.58 (+0.45%) ▲|GE324.15-1.27 (-0.39%) ▼|GEV923.91-27.13 (-2.85%) ▼|GILD144.81-0.84 (-0.58%) ▼|GM86.12+2.36 (+2.82%) ▲|GOOG330.39+2.01 (+0.61%) ▲|GOOGL332.60+1.95 (+0.59%) ▲|GS1,019.77-9.01 (-0.88%) ▼|HD305.69-4.76 (-1.53%) ▼|HON202.18-2.75 (-1.34%) ▼|IBM234.02-5.92 (-2.47%) ▼|INTC100.32-5.92 (-5.57%) ▼|INTU312.77-1.17 (-0.37%) ▼|ISRG360.46+7.22 (+2.04%) ▲|JNJ266.35-0.73 (-0.27%) ▼|JPM353.56-1.15 (-0.32%) ▼|KO87.83+0.28 (+0.32%) ▲|LIN461.62-5.03 (-1.08%) ▼|LLY1,123.00-1.21 (-0.11%) ▼|LMT530.12+5.66 (+1.08%) ▲|LOW196.59-2.01 (-1.01%) ▼|LRCX298.01-17.83 (-5.65%) ▼|MA565.37-2.13 (-0.38%) ▼|MCD253.05-0.43 (-0.17%) ▼|MDLZ62.47+0.05 (+0.08%) ▲|MDT91.62-0.27 (-0.29%) ▼|META644.38-9.31 (-1.42%) ▼|MMM162.86-1.54 (-0.94%) ▼|MO68.79+0.90 (+1.33%) ▲|MRK144.71-2.82 (-1.91%) ▼|MS212.66-2.69 (-1.25%) ▼|MSFT492.44+0.79 (+0.16%) ▲|MU977.41-50.36 (-4.90%) ▼|NEE82.44-0.21 (-0.25%) ▼|NFLX76.01-0.02 (-0.03%) ▼|NKE36.62-0.73 (-1.95%) ▼|NOW131.17+0.06 (+0.05%) ▲|NVDA218.36-5.31 (-2.37%) ▼|ORCL152.94-8.69 (-5.38%) ▼|PEP136.65-0.04 (-0.03%) ▼|PFE27.65-0.13 (-0.47%) ▼|PG142.97+0.33 (+0.23%) ▲|PLTR165.86-3.67 (-2.16%) ▼|PM189.77+4.06 (+2.19%) ▲|QCOM176.88+0.48 (+0.27%) ▲|RTX198.12+0.57 (+0.29%) ▲|SBUX99.22-0.82 (-0.82%) ▼|SCHW107.33+0.79 (+0.74%) ▲|SO87.75-0.59 (-0.67%) ▼|SPG204.67+0.14 (+0.07%) ▲|T25.55+0.40 (+1.59%) ▲|TMO603.18-2.51 (-0.41%) ▼|TMUS177.16-0.18 (-0.10%) ▼|TSLA363.56-4.25 (-1.16%) ▼|TXN258.82-2.77 (-1.06%) ▼|UBER72.56+1.48 (+2.08%) ▲|UNH388.28-4.78 (-1.22%) ▼|UNP285.78+1.04 (+0.37%) ▲|UPS99.97+0.75 (+0.76%) ▲|USB62.41+0.30 (+0.48%) ▲|V367.21-0.18 (-0.05%) ▼|VZ49.97+0.23 (+0.46%) ▲|WFC89.45-0.22 (-0.25%) ▼|WMT105.73-0.10 (-0.09%) ▼|XOM165.23+1.00 (+0.61%) ▲|AAPL326.57+11.23 (+3.56%) ▲|ABBV255.00+4.09 (+1.63%) ▲|ABT103.36-1.87 (-1.78%) ▼|ACN177.91+2.11 (+1.20%) ▲|ADBE248.83-6.03 (-2.37%) ▼|AMAT454.01-14.84 (-3.17%) ▼|AMD503.60-17.50 (-3.36%) ▼|AMGN382.47-8.80 (-2.25%) ▼|AMT172.98-2.45 (-1.40%) ▼|AMZN251.89-0.51 (-0.20%) ▼|AVGO360.83-3.55 (-0.97%) ▼|AXP320.71-1.09 (-0.34%) ▼|BA204.80-1.62 (-0.78%) ▼|BAC62.56-0.11 (-0.18%) ▼|BKNG174.33+0.90 (+0.52%) ▲|BLK1,062.40-9.63 (-0.90%) ▼|BMY63.75-0.66 (-1.02%) ▼|BNY162.59+0.08 (+0.05%) ▲|BRK-B507.00+0.28 (+0.06%) ▲|C138.50+0.70 (+0.51%) ▲|CAT805.00-10.56 (-1.29%) ▼|CL87.90-0.13 (-0.15%) ▼|CMCSA25.17+0.58 (+2.36%) ▲|COF207.11-3.75 (-1.78%) ▼|COP137.04+0.51 (+0.37%) ▲|COST902.38-0.22 (-0.02%) ▼|CRM243.00-1.16 (-0.48%) ▼|CSCO107.44-1.99 (-1.82%) ▼|CVS95.29-0.09 (-0.09%) ▼|CVX212.76-1.05 (-0.49%) ▼|DE677.94+0.73 (+0.11%) ▲|DHR200.53-4.32 (-2.11%) ▼|DIS105.82+1.64 (+1.57%) ▲|DUK119.37-1.06 (-0.88%) ▼|EMR148.37-1.97 (-1.31%) ▼|FDX311.80+2.61 (+0.84%) ▲|GD354.25+1.58 (+0.45%) ▲|GE324.15-1.27 (-0.39%) ▼|GEV923.91-27.13 (-2.85%) ▼|GILD144.81-0.84 (-0.58%) ▼|GM86.12+2.36 (+2.82%) ▲|GOOG330.39+2.01 (+0.61%) ▲|GOOGL332.60+1.95 (+0.59%) ▲|GS1,019.77-9.01 (-0.88%) ▼|HD305.69-4.76 (-1.53%) ▼|HON202.18-2.75 (-1.34%) ▼|IBM234.02-5.92 (-2.47%) ▼|INTC100.32-5.92 (-5.57%) ▼|INTU312.77-1.17 (-0.37%) ▼|ISRG360.46+7.22 (+2.04%) ▲|JNJ266.35-0.73 (-0.27%) ▼|JPM353.56-1.15 (-0.32%) ▼|KO87.83+0.28 (+0.32%) ▲|LIN461.62-5.03 (-1.08%) ▼|LLY1,123.00-1.21 (-0.11%) ▼|LMT530.12+5.66 (+1.08%) ▲|LOW196.59-2.01 (-1.01%) ▼|LRCX298.01-17.83 (-5.65%) ▼|MA565.37-2.13 (-0.38%) ▼|MCD253.05-0.43 (-0.17%) ▼|MDLZ62.47+0.05 (+0.08%) ▲|MDT91.62-0.27 (-0.29%) ▼|META644.38-9.31 (-1.42%) ▼|MMM162.86-1.54 (-0.94%) ▼|MO68.79+0.90 (+1.33%) ▲|MRK144.71-2.82 (-1.91%) ▼|MS212.66-2.69 (-1.25%) ▼|MSFT492.44+0.79 (+0.16%) ▲|MU977.41-50.36 (-4.90%) ▼|NEE82.44-0.21 (-0.25%) ▼|NFLX76.01-0.02 (-0.03%) ▼|NKE36.62-0.73 (-1.95%) ▼|NOW131.17+0.06 (+0.05%) ▲|NVDA218.36-5.31 (-2.37%) ▼|ORCL152.94-8.69 (-5.38%) ▼|PEP136.65-0.04 (-0.03%) ▼|PFE27.65-0.13 (-0.47%) ▼|PG142.97+0.33 (+0.23%) ▲|PLTR165.86-3.67 (-2.16%) ▼|PM189.77+4.06 (+2.19%) ▲|QCOM176.88+0.48 (+0.27%) ▲|RTX198.12+0.57 (+0.29%) ▲|SBUX99.22-0.82 (-0.82%) ▼|SCHW107.33+0.79 (+0.74%) ▲|SO87.75-0.59 (-0.67%) ▼|SPG204.67+0.14 (+0.07%) ▲|T25.55+0.40 (+1.59%) ▲|TMO603.18-2.51 (-0.41%) ▼|TMUS177.16-0.18 (-0.10%) ▼|TSLA363.56-4.25 (-1.16%) ▼|TXN258.82-2.77 (-1.06%) ▼|UBER72.56+1.48 (+2.08%) ▲|UNH388.28-4.78 (-1.22%) ▼|UNP285.78+1.04 (+0.37%) ▲|UPS99.97+0.75 (+0.76%) ▲|USB62.41+0.30 (+0.48%) ▲|V367.21-0.18 (-0.05%) ▼|VZ49.97+0.23 (+0.46%) ▲|WFC89.45-0.22 (-0.25%) ▼|WMT105.73-0.10 (-0.09%) ▼|XOM165.23+1.00 (+0.61%) ▲|
21.9 C
New York
Friday, September 11, 2026

Tag: options

newssourceFORcompanyinformationcontent1releasesmarket

2 in 3 Gen Z Fear They’ll Never Afford a Home — 1 in 5 Say WWIII Is More Likely to Happen First

Two-thirds (66%) of Gen Z are more concerned about housing security than a year ago, and nearly 1 in 3 (30%) have considered squatting...

CTK Bio Introduces End-to-End Solutions to Address Canada’s Single-Use Plastics Ban

CTK Bio provides certified materials and finished products through a global supply network to help Canadian businesses comply with the federal plastics ban. VANCOUVER, BC,...

Netskope Expands AI-Powered Platform Capabilities, Including New Copilot for Optimizing Universal ZTNA

Also new is the Netskope MCP server, enabling LLMs to gain context from Netskope environments, leading to more insightful analysis and automated workflows SANTA CLARA,...

E-Z-GO® Introduces Enhanced RXV Golf Car for 2026 Model Year

AUGUSTA, Ga., Aug. 5, 2025 /PRNewswire/ -- Textron E-Z-GO LLC, a Textron Inc. (NYSE: TXT) company and a leading designer and manufacturer of golf cars...

Class is in Session: 7-Eleven, Inc. Aces Breakfast with Can’t-Miss Deals

Limited-time breakfast deals are serving up big flavors and bold savings before the first bell rings IRVING, Texas, Aug. 5, 2025 /PRNewswire/ -- Pencils are...

Neuronetics Reports Second Quarter 2025 Financial and Operating Results

Delivered $38.1 million total revenue in the quarter, representing 18% adjusted pro forma revenue growth

Form 8.5 (EPT/RI) – Inspired Plc

FORM 8.5 (EPT/RI)

COURTOIS SA : Variation droits de vote 07/2025

COURTOIS S.A.

Onefxclub info Provides 24/7 Customer Support for Client Satisfaction

LAUNCESTON, Australia, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Onefxclub.info is a financial services firm recognized for offering steady and consistent support to its clients across various sectors. With a clear commitment to accessibility, the company provides 24/7 customer service to ensure every inquiry, request, and need is addressed without delay. Around-the-clock assistance remains a core part of how the organization aims to support financial stability, reduce delays in service resolution, and respond to client expectations with a sense of urgency and availability.

Tensive appoints medical device veteran Bill Hunter Chairman as its bioresorbable scaffold for breast reconstruction after cancer approaches market

Milan, Italy – August 5, 2025 – Tensive S.r.l, a clinical-stage advanced biomaterials medical device company, and the developer of REGENERA™ and SOFTAG™ bioresorbable scaffolds for breast reconstruction and tissue marking, has appointed Bill Hunter, MD, as Chairman of its Board of Directors. Dr. Hunter brings more than 30 years of leadership in the medical technology and life sciences sectors. His appointment reflects Tensive’s focus on strengthening its governance and expanding its global network as it accelerates toward pivotal clinical milestones and commercialization in the U.S. and Europe.

Sciaticyl’s “Nerve Reset” Discovery Sparks 2025 Surge in Sciatica Support Solutions Across U.S.

A powerful surge in online searches for natural sciatica remedies has thrust Sciaticyl into the spotlight, thanks to a peculiar “nerve reset” approach linked to ancient herbal wisdom and modern neuroscience. This unique formulation blends 11 ingredients—including Bacopa Monnieri, Alpha Lipoic Acid, and key nerve-regenerating compounds—positioning Sciaticyl as a leading curiosity point for those seeking non-surgical options. As nerve pain awareness grows in 2025, researchers and consumers alike are exploring how nutritional support may play a role in long-term sciatica recovery, vitality, and freedom from discomfort. 
A powerful surge in online searches for natural sciatica remedies has thrust Sciaticyl into the spotlight, thanks to a peculiar “nerve reset” approach linked to ancient herbal wisdom and modern neuroscience. This unique formulation blends 11 ingredients—including Bacopa Monnieri, Alpha Lipoic Acid, and key nerve-regenerating compounds—positioning Sciaticyl as a leading curiosity point for those seeking non-surgical options. As nerve pain awareness grows in 2025, researchers and consumers alike are exploring how nutritional support may play a role in long-term sciatica recovery, vitality, and freedom from discomfort.

Why XentaFlex Is Emerging as 2025’s Most Affordable, Simplest, and Most Effective Joint Pain Solution

More Americans Are Rethinking Collagen, Glucosamine, and Pills in 2025 as Public Curiosity Shifts Toward Ingredient-First Joint Hydration Formulas Like Simple Promises' XentaFlex 
More Americans Are Rethinking Collagen, Glucosamine, and Pills in 2025 as Public Curiosity Shifts Toward Ingredient-First Joint Hydration Formulas Like Simple Promises' XentaFlex

Innovent Receives U.S. FDA Approval for IND Application of Oral GLP-1R Agonist IBI3032

SAN FRANCISCO and SUZHOU, China, Aug. 4, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality...

NUTEX ALERT: Bragar Eagel & Squire, P.C. is Investigating Nutex Health Inc. on Behalf of Nutex Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nutex (NUTX) To Contact Him Directly To Discuss Their Options

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsOptions

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers